Company Profile (AI Text) Name: Maxwell Biosciences Canonical URL: https://wefunder.com/maxwell.biosciences Updated at: 2026-11-19T23:52:56Z Tagline: Destroys Most Infections with One Nontoxic Molecule. 10 Year FDA Exclusivity on All-Cause Pneumonia. Key claims: - Total raised on Wefunder: 351500 | citation: https://wefunder.com/maxwell.biosciences#claim-total-raised - Total investors: 32 | citation: https://wefunder.com/maxwell.biosciences#claim-total-investors Verified facts: - Total raised on Wefunder: 351500 | observed_at: 2026-11-19T23:52:56Z | expires_at: 2026-11-20T23:52:56Z - Total investors: 32 | observed_at: 2026-11-19T23:52:56Z | expires_at: 2026-11-20T23:52:56Z Computed metrics: - total_amount_raised: 351500 - total_investors: 32 - team_size: 9 - featured_investor_count: 4 - faq_count: 2 - recent_post_count: 0 Quick facts: - FDA QIDP in bacterial & fungal pneumonia: FDA Fast Track, Priority Review, 10-yr exclusivity | citation: https://wefunder.com/maxwell.biosciences#claim-fact-1 - Govt-sponsored primate study: MRSA & Candida cleared from the head in 3 days, no toxicity | citation: https://wefunder.com/maxwell.biosciences#claim-fact-2 - $69M+ in funding & grants; government backing from US, Australia, India, S. Korea & Japan | citation: https://wefunder.com/maxwell.biosciences#claim-fact-3 - 7 signed U.S. military R&D agreements (CRADAs) + a $3M U.S. Army MTEC award, all non-dilutive | citation: https://wefunder.com/maxwell.biosciences#claim-fact-4 - Novel membrane + DNA/RNA mechanism showed no bacterial resistance across 30 lab passages | citation: https://wefunder.com/maxwell.biosciences#claim-fact-5 - Backed by 500+ peer-reviewed published studies; published in-vivo efficacy, safety and no resistance | citation: https://wefunder.com/maxwell.biosciences#claim-fact-6 - A platform, not one drug: AI designs Claromers that mimic the body's own immune peptides | citation: https://wefunder.com/maxwell.biosciences#claim-fact-7 - Board includes Eli Lilly President, Ret. U.S. Army biodefense commanding General, former Congressman | citation: https://wefunder.com/maxwell.biosciences#claim-fact-8 FAQ: - Q: How do I invest from Switzerland? A: Hi Fiona, a wire & here are instructions: https://help.wefunder.com/article/2b5235b1-2-international-investor-guide. - Q: Most, if not all, of the papers you link to in your deck came out of Annelise Barron’s lab at Stanford. Is she, or any of her former students, affiliated with Maxwell Biosciences? Who is leading your R&D efforts? Is that work being performed in-house, or by a contract lab?... A: Good question, Jason. Yes! Prof Barron is the scientific cofounder of Maxwell. Dr Sheetal Vali, PhD is our head of R&D. The lab work is being done by contract labs and by military, NIH, India Government, etc. The IP is super strong. We have 11 granted patents and 48 pending patents. All owned by Maxwell, 100%. Thanks for your questions! I'm available to answer any other questions. - Scotch